These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36623977)

  • 1. Quantitative MRI evaluation of bone marrow in sickle cell disease: relationship with haemolysis and clinical severity.
    Lins CF; Salmon CEG; Amorim de Souza L; Quesado RCS; de Souza Moraes R; Silva-Pinto AC; Matos MA; Nogueira-Barbosa MH
    Clin Radiol; 2023 Mar; 78(3):e268-e278. PubMed ID: 36623977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualitative and quantitative magnetic resonance imaging evaluation of bone tissue vaso-occlusive events in patients with sickle cell disease.
    Lins CF; Salmon CEG; de Souza LA; Moraes RS; Silva-Pinto AC; Matos MA; Nogueira-Barbosa MH
    Bone; 2021 Jul; 148():115961. PubMed ID: 33866047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.
    Drawz P; Ayyappan S; Nouraie M; Saraf S; Gordeuk V; Hostetter T; Gladwin MT; Little J
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):207-15. PubMed ID: 26672090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel permeability characteristics of red blood cells from sickle cell patients heterozygous for HbS and HbC (HbSC genotype).
    Dalibalta S; Ellory JC; Browning JA; Wilkins RJ; Rees DC; Gibson JS
    Blood Cells Mol Dis; 2010 Jun; 45(1):46-52. PubMed ID: 20227897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six-point DIXON and Magnetic Resonance Spectroscopy Techniques in Quantifying Bone Marrow Fat in Sickle Cell Disease.
    Lins CF; Salmon CEG; de Souza LA; Moraes RS; Silva-Pinto AC; Matos MA; Nogueira-Barbosa MH
    Acad Radiol; 2022 May; 29(5):e73-e81. PubMed ID: 34257024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of hemolysis on plasma oxidation and nitration in patients with sickle cell disease.
    Kupesiz A; Celmeli G; Dogan S; Antmen B; Aslan M
    Free Radic Res; 2012 Jul; 46(7):883-90. PubMed ID: 22509726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total Serum Magnesium Levels and Calcium-To-Magnesium Ratio in Sickle Cell Disease.
    Antwi-Boasiako C; Kusi-Mensah YA; Hayfron-Benjamin C; Aryee R; Dankwah GB; Kwawukume LA; Darkwa EO
    Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31470666
    [No Abstract]   [Full Text] [Related]  

  • 8. Abnormality of erythrocyte membrane n-3 long chain polyunsaturated fatty acids in sickle cell haemoglobin C (HbSC) disease is not as remarkable as in sickle cell anaemia (HbSS).
    Ren H; Ghebremeskel K; Okpala I; Ugochukwu CC; Crawford M; Ibegbulam O
    Prostaglandins Leukot Essent Fatty Acids; 2006 Jan; 74(1):1-6. PubMed ID: 16314081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of the haemoglobin level in patients with sickle cell disease living in sub-Saharan Africa: Major impact of the country of residence and independent effects of leucocyte and platelet counts and haemolysis.
    Rossi M; Belinga S; Tolo A; Diop S; Diagne I; Chelo D; Wamba G; Gonzalez JP; Abough'elie C; Traore Y; Deme-Ly I; Seck M; Diaw M; Gbonon V; Boidy K; Kamara I; Kitenge R; Jouven X; Tshilolo L; Diallo D; Ranque B
    Br J Haematol; 2024 Aug; 205(2):664-673. PubMed ID: 38831605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance P is increased in patients with sickle cell disease and associated with haemolysis and hydroxycarbamide use.
    Brandow AM; Wandersee NJ; Dasgupta M; Hoffmann RG; Hillery CA; Stucky CL; Panepinto JA
    Br J Haematol; 2016 Oct; 175(2):237-245. PubMed ID: 27539682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine and metabolic complications in children and adolescents with Sickle Cell Disease: an Italian cohort study.
    Mandese V; Bigi E; Bruzzi P; Palazzi G; Predieri B; Lucaccioni L; Cellini M; Iughetti L
    BMC Pediatr; 2019 Feb; 19(1):56. PubMed ID: 30744584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severity of Brazilian sickle cell disease patients: severity scores and feasibility of the Bayesian network model use.
    Belini Junior E; Silva DG; Torres Lde S; Okumura JV; Lobo CL; Bonini-Domingos CR
    Blood Cells Mol Dis; 2015 Apr; 54(4):321-7. PubMed ID: 25842370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and correlates of growth failure in young African patients with sickle cell disease.
    Alexandre-Heymann L; Dubert M; Diallo DA; Diop S; Tolo A; Belinga S; Sanogo I; Diagne I; Wamba G; Boidy K; Ly ID; Kamara I; Traore Y; Offredo L; Jouven X; Ranque B
    Br J Haematol; 2019 Jan; 184(2):253-262. PubMed ID: 30467843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Most adults with severe HbSC disease are not treated with hydroxyurea.
    Ghunney WK; Asare EV; Ayete-Nyampong JB; Oppong SA; Rodeghier M; DeBaun MR; Olayemi E
    Blood Adv; 2023 Jul; 7(13):3312-3319. PubMed ID: 36799926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
    Nevitt SJ; Jones AP; Howard J
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002202. PubMed ID: 28426137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sickle cell diseases: What can nuclear medicine offer?
    Niccoli Asabella A; Altini C; Nappi AG; Lavelli V; Ferrari C; Marzullo A; Loiodice A; Rubini G
    Hell J Nucl Med; 2019; 22(1):2-3. PubMed ID: 30843001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher rates of hemolysis are not associated with albuminuria in Jamaicans with sickle cell disease.
    Asnani MR; Fraser RA; Reid ME
    PLoS One; 2011 Apr; 6(4):e18863. PubMed ID: 21533141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sickle cell disease: A distinction of two most frequent genotypes (HbSS and HbSC).
    da Guarda CC; Yahouédéhou SCMA; Santiago RP; Neres JSDS; Fernandes CFL; Aleluia MM; Figueiredo CVB; Fiuza LM; Carvalho SP; Oliveira RM; Fonseca CA; Ndidi US; Nascimento VML; Rocha LC; Goncalves MS
    PLoS One; 2020; 15(1):e0228399. PubMed ID: 31995624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of the coinheritance of Glucose-6-phosphate dehydrogenase deficiency on the severity of sickle cell disease.
    Fasola FA; Fowodu FO; Shokunbi WA; Kotila TR
    Niger Postgrad Med J; 2019; 26(2):118-122. PubMed ID: 31187752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocytosis is associated with hemolysis in sickle cell disease.
    Wongtong N; Jones S; Deng Y; Cai J; Ataga KI
    Hematology; 2015 Dec; 20(10):593-7. PubMed ID: 25875078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.